ScoreWhy is Jubilant Pharmova Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of -3.22% and Operating profit at -10.65% over the last 5 years
2
With a growth in Net Profit of 89.49%, the company declared Very Positive results in Dec 24
- The company has declared positive results for the last 6 consecutive quarters
- PBT LESS OI(Q) At Rs 140.20 cr has Grown at 115.03 %
- ROCE(HY) Highest at 8.37 %
- INVENTORY TURNOVER RATIO(HY) Highest at 5.92 times
3
Stock is technically in a Mildly Bearish range
- The technical trend has deteriorated from Mildly Bullish on 07-Mar-25 and has generated -1.65% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
With ROCE of 8.2, it has a Very Attractive valuation with a 1.9 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 38.06%, its profits have risen by 1059.7% ; the PEG ratio of the company is 0
5
High Institutional Holdings at 23.94%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Jubilant Pharmo should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Drugs should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jubilant Pharmo for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Jubilant Pharmo
38.38%
0.85
44.71%
SENSEX
0.45%
0.03
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-3.22%
EBIT Growth (5y)
-10.65%
EBIT to Interest (avg)
3.62
Debt to EBITDA (avg)
3.20
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.76
Tax Ratio
13.55%
Dividend Payout Ratio
102.46%
Pledged Shares
0
Institutional Holding
23.94%
ROCE (avg)
10.04%
ROE (avg)
7.91%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
30
Industry P/E
33
Price to Book Value
2.23
EV to EBIT
20.99
EV to EBITDA
13.84
EV to Capital Employed
1.92
EV to Sales
2.15
PEG Ratio
0.03
Dividend Yield
0.60%
ROCE (Latest)
8.22%
ROE (Latest)
6.57%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend26What is working for the Company
PBT LESS OI(Q)
At Rs 140.20 cr has Grown at 115.03 %
ROCE(HY)
Highest at 8.37 %
INVENTORY TURNOVER RATIO(HY)
Highest at 5.92 times
DEBTORS TURNOVER RATIO(HY)
Highest at 8.65 times
OPERATING PROFIT TO INTEREST(Q)
Highest at 5.17 times
PAT(Q)
At Rs 115.48 cr has Grown at 72.9 %
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 1,077.40 cr
DEBT-EQUITY RATIO(HY)
Lowest at 0.52 times
NET SALES(Q)
Highest at Rs 1,821.70 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Jubilant Pharmo
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 140.20 cr has Grown at 115.03 %
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 5.17 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit After Tax (PAT) - Quarterly
At Rs 115.48 cr has Grown at 72.9 %
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Inventory Turnover Ratio- Half Yearly
Highest at 5.92 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio- Half Yearly
Highest at 8.65 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Net Sales - Quarterly
Highest at Rs 1,821.70 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 140.20 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 115.48 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 1,077.40 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio - Half Yearly
Lowest at 0.52 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
